Saliva Collection and Diagnostics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 10.10 % |
| Fastest Growing Market | North America |
| Largest Market | Asia-Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Saliva Collection and Diagnostics Market Analysis
The saliva collection and diagnosis market are projected to register a CAGR of 10.1% during the forecast period (2022-2027).
COVID-19 has had a significant impact on the growth of the market, owing to the rising cases of infectious diseases among people and an increased preference for non-invasive and self-saliva-based tests. The increase in the need to diagnose COVID-19 infected patients created lucrative opportunities for the saliva collection and diagnosis market. For instance, according to the World Health Organization (WHO), in January 2022, the number of new COVID-19 cases increased by 5% across the globe from January 17th to January 23rd, 2022. Additionally, initiatives taken by the market players also contributed to the growth of the market. For instance, in December 2021, Cotipharma launched a saliva-based Omicron detecting PCR test in Africa. This test is CE-marked and can detect all known variants of SARS-CoV-2, including Omicron. Thus, COVID-19 is expected to have a significant impact on the growth of the market.
Furthermore, the increasing prevalence of infectious diseases among people across the globe is assumed to be one of the major driving factors for market growth. According to the World Health Organization (WHO), in 2021, 60% of the global population suffered from infectious diseases. The report also stated that infectious diseases kill over 17 million people a year, which illustrates the global burden of infectious diseases. The rise in the number of infectious cases has led to the demand for safe and effective diagnostic tests and products. Hence, saliva collection and diagnosis play a major role as a non-invasive diagnostic method for screening patients for several diseases.
Moreover, the increase in product approvals for saliva collection and diagnostic products is a significant factor likely to augment the market's growth. For instance, in July 2021, Hologic Inc.'s HOLX optima SARS-COV-2 molecular diagnostic test received CE marking by the European Union for its use with a saliva sample.
Additionally, the initiatives taken by the public authorities are also propelling the growth of the market. For instance, in August 2022, Australia launched one of the world's first preventative DNA screening programs for cancer and heart disease risk through free DNA saliva tests. It is a nationally collaborative project, led by Australia's Monash University. Furthermore, the initiatives taken by market players to support labs in conducting scientific studies using banked saliva samples, taking advantage of a sample type that is easy to access and non-invasive, are expected to have a positive impact on the growth of the market. For instance, in September 2021, Thermo Fisher Scientific launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit, which is designed to safely collect saliva for research. Such initiatives also contribute to the growth of the market.
Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of collection devices may impede the growth of the market.
Saliva Collection and Diagnostics Market Trends
This section covers the major market trends shaping the Saliva Collection & Diagnosis Market according to our research experts:
The Diagnostic Laboratories Segment is Expected to Hold a Major Market Share Over the Forecast Period
The diagnostic laboratories sub-segment by application is expected to drive the market's growth due to the increasing usage of saliva collection and diagnosis across laboratories. Factors contributing to the growth of the segment include the increasing prevalence of infectious and chronic diseases; ease of conduct; the growing number of standalone diagnostic laboratories as well as in-built diagnostic labs within healthcare settings; and the availability of skilled professionals.
The sudden outbreak of COVID-19 has increased the demand for saliva collection and diagnosis due to the surge in the number of infectious cases of COVID-19 disease across the world. Diagnostic laboratories play a crucial role in testing and diagnosing patients with COVID-19 and various other diseases owing to advanced equipment and quicker results, as a result of which, the segment is expected to project growth over the analysis period.
Moreover, the rising prevalence of chronic diseases such as cancer among people has led to the increasing use of non-invasive screening methods in diagnostic laboratories. For instance, the American Cancer Society's 2022 statistics estimated that about 54,000 new cases of the oral cavity or oropharyngeal cancer will be diagnosed in 2022 in the United States. Saliva collection and diagnosis is widely used in cancer diagnosis in diagnostic laboratories owing to its accuracy and painless procedure.
The launch of new products is also propelling the growth of the market segment. For instance, in June 2022, Goodbody Health Inc. launched four saliva tests that can determine a person's risk of getting cancer or heart disease over ten years via looking at genetics. Such launches are expected to propel the growth of the segment over the coming years.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
North America is expected to hold a significant share in the market owing to the increasing prevalence of infectious diseases, growing preference for saliva tests, and the launch of newer products by the market players and others.
The increasing prevalence of chronic diseases in the United States contributes to the growing demand for saliva collection and diagnosis products. According to the American Cancer Society, 2022 statistics, it was estimated that in the United States there are about 38,700 males and 15,300 females living with oral and pharynx cancer. Similarly, according to statistics published by MedAlertHelp, in 2022, about 5% to 20% of Americans are diagnosed with influenza every year. Furthermore, according to the data published by the Centers for Disease Control and Prevention in October 2021, overall, 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits were reported in the 2019-2020 season. Such a growing burden of disease is creating demand for saliva collection and diagnosis, thus driving the growth of the market in the region.
Moreover, the launch of products is expected to drive the growth of the regional market. For instance, in August 2022, Viome Life Sciences launched CancerDetect, a diagnostic test for oral and throat cancer that uses mRNA technology and an AI-powered platform. Additionally, in September 2021, Thermo Fisher Scientific launched the SpeciMax Stabilized Saliva Collection Kit, which is designed to safely collect saliva for research. This kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses.
Thus, owing to the abovementioned factors, the studied market in the region is expected to grow over the forecast period.
Saliva Collection and Diagnostics Industry Overview
The saliva collection and diagnosis market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Thermo Fisher Scientific, Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen, Inc., Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc., Arcis Bio, Orasure Technologies, and others.
Saliva Collection and Diagnostics Market Leaders
-
ThermoFisher Scientific
-
Abbott
-
Neogen Corporation
-
Sarstedt AG&Co.KG-
-
Autogen Inc
*Disclaimer: Major Players sorted in no particular order
Saliva Collection and Diagnostics Market News
- In August 2022, LordsMed entered into an exclusive partnership with Singapore-based diagnostics kit manufacturer Sensing Self to bring one of the world's first COVID-19 saliva-based rapid antigen test kits to India.
- In January 2022, Eurobio Scientific entered into an exclusive distribution contract with Orasure for the commercialization of OraQuick, a saliva self-test. This exclusive contract includes the French market and its overseas territories.
Saliva Collection and Diagnostics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Infectious Diseases Among the Population
- 4.2.2 Rising Application of Non- Invasive Saliva testing as a Replacement of Blood Testing
-
4.3 Market Restraints
- 4.3.1 High Costs of Collection Devices
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value -USD million)
-
5.1 By Site of Collection
- 5.1.1 Parotid Gland Collection
- 5.1.2 Submandibular collection
- 5.1.3 Minor Salivary Glands Collection
-
5.2 By Application
- 5.2.1 Diagnostic Laboratories
- 5.2.2 Forensics
- 5.2.3 Others
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Thermo Fisher Scientific
- 6.1.2 Neogen Corporation
- 6.1.3 Abbott
- 6.1.4 Sarstedt AG and Co.KG
- 6.1.5 Autogen Inc
- 6.1.6 Oasis Diagnostics
- 6.1.7 Porex
- 6.1.8 Salimetrics, LLC
- 6.1.9 Takara Bio, Inc
- 6.1.10 Arcis Bio
- 6.1.11 Orasure Technologies
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablitySaliva Collection and Diagnostics Industry Segmentation
As per the scope of this report, the saliva collection and diagnosis is a transport and collection system used for collecting clinical specimens for diagnostic purposes. The Saliva Collection and Diagnosis Market is Segmented by Site of Collection (Parotid Gland Collection, Submandibular Collection, and Minor Salivary Glands Collection), By Application (Diagnostic Laboratories, Forensic and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD Million) for the above segments. The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.
| By Site of Collection | Parotid Gland Collection | |
| Submandibular collection | ||
| Minor Salivary Glands Collection | ||
| By Application | Diagnostic Laboratories | |
| Forensics | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Saliva Collection and Diagnostics Market Research FAQs
What is the current Global Saliva Collection and Diagnosis Market size?
The Global Saliva Collection and Diagnosis Market is projected to register a CAGR of 10.10% during the forecast period (2024-2029)
Who are the key players in Global Saliva Collection and Diagnosis Market?
ThermoFisher Scientific, Abbott, Neogen Corporation, Sarstedt AG&Co.KG- and Autogen Inc are the major companies operating in the Global Saliva Collection and Diagnosis Market.
Which is the fastest growing region in Global Saliva Collection and Diagnosis Market?
North America is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Saliva Collection and Diagnosis Market?
In 2024, the Asia-Pacific accounts for the largest market share in Global Saliva Collection and Diagnosis Market.
What years does this Global Saliva Collection and Diagnosis Market cover?
The report covers the Global Saliva Collection and Diagnosis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Saliva Collection and Diagnosis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
POC Blood Gas and Electrolyte Industry Report
Statistics for the 2024 POC Blood Gas and Electrolyte market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. POC Blood Gas and Electrolyte analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
